- Home
- ATYR vs URG Comparison
ATYR vs URG Comparison
Compare ATYR & URG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- URG
- Stock Information
- Founded
- ATYR 2005
- URG 2004
- Country
- ATYR United States
- URG United States
- Employees
- ATYR N/A
- URG N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- URG Precious Metals
- Sector
- ATYR Health Care
- URG Basic Materials
- Exchange
- ATYR Nasdaq
- URG Nasdaq
- Market Cap
- ATYR 306.2M
- URG 394.0M
- IPO Year
- ATYR 2015
- URG N/A
- Fundamental
- Price
- ATYR $5.28
- URG $1.07
- Analyst Decision
- ATYR Strong Buy
- URG Strong Buy
- Analyst Count
- ATYR 6
- URG 2
- Target Price
- ATYR $20.20
- URG $2.45
- AVG Volume (30 Days)
- ATYR 3.5M
- URG 10.0M
- Earning Date
- ATYR 08-12-2025
- URG 08-08-2025
- Dividend Yield
- ATYR N/A
- URG N/A
- EPS Growth
- ATYR N/A
- URG N/A
- EPS
- ATYR N/A
- URG N/A
- Revenue
- ATYR N/A
- URG $33,706,000.00
- Revenue This Year
- ATYR $960.85
- URG N/A
- Revenue Next Year
- ATYR $1,283.47
- URG $251.38
- P/E Ratio
- ATYR N/A
- URG N/A
- Revenue Growth
- ATYR N/A
- URG 200.09
- 52 Week Low
- ATYR $1.48
- URG $0.55
- 52 Week High
- ATYR $5.98
- URG $1.53
- Technical
- Relative Strength Index (RSI)
- ATYR 58.81
- URG 60.11
- Support Level
- ATYR $4.78
- URG $1.00
- Resistance Level
- ATYR $5.50
- URG $1.11
- Average True Range (ATR)
- ATYR 0.38
- URG 0.07
- MACD
- ATYR -0.08
- URG -0.00
- Stochastic Oscillator
- ATYR 60.24
- URG 68.75
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.